DRUG - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

DRUG is currently covered by 5 analysts with an average price target of $139.8. This is a potential upside of $119.4 (585.29%) from yesterday's end of day stock price of $20.4.

DRUG's activity chart (see below) currently has 14 price targets and 22 ratings on display. The stock rating distribution of DRUG is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 52% of the time, taking 187.6 days on average.

Highest price target for DRUG is $220, Lowest price target is $80, average price target is $139.8.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 03-Nov-2026. First documented stock forecast 25-Nov-2024.

Currently out of the existing stock ratings of DRUG, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Nov-2024

$107

$86.6 (424.51%)

$126

19 days ago
(03-Nov-2026)

2/5 (40%)

$85.45 (396.52%)

204

Buy Since 10-Jan-2025

$145

$124.6 (610.78%)

$145

3 months 3 days ago
(19-Aug-2026)

4/8 (50%)

$60.26 (71.11%)

208

Buy Since 08-Sep-2025

$147

$126.6 (620.59%)

$147

3 months 5 days ago
(17-Aug-2026)

1/5 (20%)

$67.52 (84.95%)

86

Buy Since 23-Jan-2025

$220

$199.6 (978.43%)

$93

6 months 2 days ago
(20-May-2026)

1/2 (50%)

$137.22 (165.76%)

327

Buy Since 21-May-2025

$80

$59.6 (292.16%)

$80

10 months 20 days ago
(02-Jan-2026)

2/2 (100%)

$-3.46 (-4.15%)

113

Show more analysts

Please expand the browser size to see the chart

What is DRUG average time for price targets to be met?

On average it took 188 days for the stock forecasts to be reached, with an average price target met ratio of 52%.

Which analyst most recently updated their price target on DRUG?

Joel Beatty

Which analyst has the lowest performance score on DRUG with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on DRUG?

Joel Beatty works at BAIRD and has 6 price targets and 5 ratings on DRUG

Which analyst is the currently most bullish on DRUG?

Yasmeen Rahimi with the highest potential upside of $199.6

Which analyst is the currently most reserved on DRUG?

Rudy Li with the lowest potential downside of $59.6
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?